Kurebayashi Junichi
Department of Breast and Thyroid Surgery, Kawasaki Medical School, Japan.
Breast Cancer. 2007;14(2):200-14. doi: 10.2325/jbcs.954.
Breast cancer is a hormone-dependent cancer like prostate cancer and endometrial cancer. Estrogen plays important roles in the development and progression of breast cancer. Endocrine therapy is the treatment of choice for estrogen receptor- and/or progesterone receptor-positive breast cancer. Endocrine therapy has been used for several purposes, including chemoprevention, preoperative treatment, postoperative adjuvant treatment and treatment for recurrent diseases. A large number of clinical trials have provided evidence showing the clinical benefits of various endocrine therapies for the treatment of breast cancer. The current status and recent advances in endocrine therapy for breast cancer are reviewed based on the results of current clinical trials. Future perspectives of endocrine therapy are also discussed.
乳腺癌是一种像前列腺癌和子宫内膜癌一样依赖激素的癌症。雌激素在乳腺癌的发生和发展中起着重要作用。内分泌治疗是雌激素受体和/或孕激素受体阳性乳腺癌的首选治疗方法。内分泌治疗已用于多种目的,包括化学预防、术前治疗、术后辅助治疗和复发性疾病的治疗。大量临床试验提供了证据,表明各种内分泌治疗对乳腺癌治疗具有临床益处。基于当前临床试验结果,对乳腺癌内分泌治疗的现状和最新进展进行了综述。还讨论了内分泌治疗的未来前景。